Gilead Sciences



Ebit Cambio Fecha
AbbVie USD 5.24B 1.5B 2024-12
Agios Pharmaceuticals USD -125037000 22.23M 2024-12
ALKERMES USD 162.69M 46.46M 2024-12
Alnylam Pharmaceuticals USD -105159000 28.25M 2024-12
Amgen USD 4.03B 11M 2024-12
Biogen USD 644.1M 100.9M 2024-12
BioMarin Pharmaceutical USD 161.41M 47.51M 2024-12
Bristol-Myers Squibb USD 4.21B 500M 2024-12
Eli Lilly USD 5.63B 3.88B 2024-12
Gilead Sciences USD 3.11B 144M 2024-12
GlaxoSmithKline GBP 1.43B 1.33B 2024-12
Glaxosmithkline GBP 1.83B 1.76B 2024-12
Incyte USD 376.26M 121.03M 2024-12
J&J USD 5.35B 1.14B 2024-12
Merck USD 5.22B 339M 2024-12
Moderna USD -1246000000 1.18B 2024-12
Neurocrine Biosciences USD 142M 41.8M 2024-12
Novartis USD 4.86B 286M 2024-12
Pfizer USD 4.62B 2.42B 2024-12
PTC Therapeutics USD -162389000 107.88M 2024-12
Regeneron Pharmaceuticals USD 1.57B 67.9M 2024-12
Sanofi EUR 2.08B 1.69B 2024-12
Sarepta Therapeutics USD 161.68M 139.48M 2024-12
United Therapeutics USD 357.7M 14.6M 2024-12
Vertex Pharmaceuticals USD 1.2B 108.8M 2024-12



Gilead Sciences - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Mar 2025.